Tag: upadacitinib

Non-TNF-targeted therapies more effective than anti-TNF agents in uncontrolled rheumatoid arthritis

Upadacitinib may be superior to abatecept for refractory rheumatoid arthritis

byHarsh Shahand1 others

November 2, 2020

1. Upadacitinib was superior to abatacept in achieving remission at 12 weeks for patients with rheumatoid arthritis refractory to biologic ...

Page 2 of 2 Prev 1 2

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Perioperative toripalimab improves event-free survival in non-small cell lung cancer
Antithrombotic agents may be effective in preventing migraine in patients with patent foramen ovale
Active surveillance is cost-effective compared with standard surgery among esophageal cancer patients with complete clinical response after neoadjuvant chemoradiotherapy

No Result

View All Result